Post Thu Mar 09, 2017 5:15 pm

2017-Buckle et al-Theranostics

"Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics"
Buckle Tessa; van der Wal Steffen; Kuil Joeri; van Malderen Stijn J M; Vanhaeke Frank; Muller Larissa; van Unen Vincent; Peters Ruud J B; van Bemmel Margaretha E M; Koning Frits; McDonnell Liam A; Velders Aldrik H; van Leeuwen Fijs W B
Theranostics. 2017, 7, 624-633
http://dx.doi.org/10.7150/thno.17484

-combines Cy3 for fluorescence and a DTPA chelator for radioimaging (111In) or CyTOF (165Ho) for a CXCR4-specific peptide.